After more than a century of effort, atherosclerosis smooth muscle cells and collagen matrix are described by research has finally, in the last 10 years or so, progressed van der Wal and Becker [3] . The biological factors, from understanding pathogenesis to establishment of suc-prominently inflammation and matrix degradation, and biocessful treatments. Dietary intervention with oily fish, daily mechanical factors, prominently locally increased wall ingestion of aspirin, as antiplatelet therapy, and latterly stress, that underlie the association of these pathological cholesterol lowering have provided significant reduction of features with the final rupture event are discussed by risk of subsequent coronary events, including unstable Arroyo and Lee [4] . Several articles then expand on angina and myocardial infarction. The trial evidence is important individual facets of the morphogenesis of stable now so convincing, as is being reviewed by Rabbani and and unstable plaques, which include vascular smooth Topol [1] , that the debate has moved on from ''whether to muscle cell proliferation, migration and matrix formation treat'' to ''whom to treat'', a judgement based on health (Newby and Zaltsman [5] ), apoptosis of smooth muscle economic considerations influenced by the balance of cells (Bennett [6] ), collagen synthesis (Rekhter [7] ) and benefits and risks. One of the challenges for health the role of intercellular adhesion molecules expressed on planners is that the benefits of these interventions, while smooth muscle cells (Braun et al. [8] ). A consensus highly significant, are arguably modest, amounting to a emerges that these processes are in delicate balance and 50% or so overall risk reduction [1] . Moreover, the have potentially opposing roles in plaque progression and reduction in risk is spread evenly over high and low risk destabilisation. Siow et al. [9] contribute a provocative groups, which implies the need to treat many healthy article proposing a hitherto unappreciated role for the heme individuals to prevent each clinical event. One response to oxygenase-carbon monoxide pathway in atherogenesis. this situation would be to hope that, as statins become Finally, Bates and Weitz [10] consider what new therapeugeneric drugs, treatments will become inexpensive enough tic possibilities exist for modulating thrombus formation to apply on a population-wide basis. A second more on unstable plaques and hence preventing progression to exciting and dynamic approach is to build on the ''proof of the clinically overt syndromes of unstable angina and principle'' provided by the existing trial successes to myocardial infarction. Original articles encompass new develop more targeted and effective treatments. This latter data regarding local arterial wall remodeling (Smits et al. approach provides the backdrop to this focussed issue.
[11]) the role of plaque microvasculature (de Boer et al. There is emerging consensus that plaque instability rather
[12]), smooth muscle proliferation (Lutgens et al. [13] ), than progression should be the proper target for new and apoptosis (Bauriedel et al. [14] ) therein. The specific therapies, because it is instability that underlies most role of genes, overexpressed in plaques, such as nitric clinical events (see for review Gutstein and Fuster [2] ). oxide synthase (Depre et al. [15] ) and 12-lipoxygenase The pathological features associated with plaque instabili-(Natarajan et al. [16] ) is also considered. New insights into ty, namely a thin fibrous cap, large lipid pool and the collagen induced platelet aggregation are presented by preponderance within plaques of inflammatory cells over Knight et al. [17] and a new approach to reducing restenosis after angioplasty and stenting is described by 
